Home > Insider Trading > Filing (0001628280-24-000698)

Filing Details

Accession Number:: 0001628280-24-000698
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-05 17:33:36
Reporting Period:: 2024-01-03

Accepted Time:: 2024-01-05 17:33:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1930805	Drayton John Wise	700 Us Highway 202/206 Bridgewater NJ 08807	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Stock Option (Right To Buy)	Acquisiton	2024-01-03	20,071	$19.11	124,055	No	4	M	Direct
Stock Option (Right To Buy)	Disposition	2024-01-03	20,071	$29.19	103,984	No	4	S	Direct
Common Stock	Acquisiton	2024-01-04	12,873	$0.00	116,857	No	4	A	Direct
Common Stock	Disposition	2024-01-05	1,167	$29.32	115,690	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-01-03	20,071	$0.00	20,071	$19.11
Common Stock	Stock Option (right to buy)	Acquisiton	2024-01-04	63,560	$0.00	63,560	$29.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-02-10	No	4	M	Direct
63,560		2034-01-04	No	4	A	Direct

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
This is the weighted average sales price representing 20,071 shares sold at prices ranging from $28.915 to $29.39 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.
Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.
Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.